| scholarly article | Q13442814 |
| P50 | author | Joshua Stein | Q78679817 |
| P2093 | author name string | Terry J Smith | |
| Raymond Douglas | |||
| Shivani Gupta | |||
| Bin Nan | |||
| Nidhi Talwar | |||
| Brian J Lee | |||
| David Childers | |||
| P2860 | cites work | Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis | Q21144329 |
| Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study | Q28255453 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Immunopathogenesis of thyroid eye disease: emerging paradigms | Q33789467 | ||
| Statins as potential therapeutic agents in neuroinflammatory disorders | Q34213875 | ||
| Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial | Q34275827 | ||
| Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 | ||
| C-Reactive Protein: How Has JUPITER Impacted Clinical Practice? | Q34986430 | ||
| Differences in rates of glaucoma among Asian Americans and other racial groups, and among various Asian ethnic groups | Q35028265 | ||
| The relationship between components of metabolic syndrome and open-angle glaucoma | Q35085705 | ||
| Statins and their potential targets in multiple sclerosis therapy | Q35537898 | ||
| Anti-inflammatory effects of statins: clinical evidence and basic mechanisms | Q36337932 | ||
| Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease | Q36481812 | ||
| The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease | Q37491763 | ||
| Statins as emerging treatments for asthma and chronic obstructive pulmonary disease | Q37754865 | ||
| Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study | Q38471162 | ||
| Long-term follow-up of Graves ophthalmopathy in an incidence cohort | Q40994540 | ||
| Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis | Q43109248 | ||
| A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. | Q43125924 | ||
| Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study | Q43198503 | ||
| Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients | Q44015510 | ||
| Statin use in patients with asthma: a nationwide population-based study | Q44374077 | ||
| A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma | Q44772777 | ||
| Oral simvastatin treatment in relapsing-remitting multiple sclerosis | Q44897670 | ||
| Longitudinal correlation of thyroid-stimulating immunoglobulin with clinical activity of disease in thyroid-associated orbitopathy | Q46236669 | ||
| Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial | Q51652663 | ||
| Effect of Abnormal Thyroid Function on the Severity of Graves' Ophthalmopathy | Q67657511 | ||
| Prevalence of ophthalmopathy in Basedow disease. Follow-up of patients one year following diagnosis of hyperthyroidism | Q72197347 | ||
| Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? | Q72414211 | ||
| The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole | Q72686368 | ||
| Clinical relevance of thyroid-stimulating immunoglobulins in graves' ophthalmopathy | Q84389014 | ||
| Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131 | Q84506454 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 290-296 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease | |
| P478 | volume | 133 |
| Q89620715 | Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy |
| Q87885684 | Extraocular muscle repositioning as the last therapeutic option for a patient with a severe course of Graves' Ophthalmopathy: a case report |
| Q38925795 | Geographic Variation in the Rate and Timing of Cataract Surgery Among US Communities. |
| Q47399634 | Geriatric patients are predisposed to strabismus following thyroid-related orbital decompression surgery: A multivariate analysis |
| Q26782424 | Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management |
| Q36811275 | Guidance on That Damned Elusive Orbitopathy of Graves' Disease |
| Q93377461 | Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves' orbitopathy: a case series |
| Q37054144 | Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease. |
| Q42656691 | Prognostic indicators for the development of strabismus among patients with graves' ophthalmopathy |
| Q36833918 | Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy |
| Q89161351 | Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study |
| Q58606862 | Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy |
| Q92501730 | Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves' ophthalmopathy patients |
| Q38888403 | Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease |
| Q86387770 | Statin reduces orbitopathy risk in patients with Graves' disease by modulating apoptosis and autophagy activities |
| Q55016513 | Transcriptome Analysis of Orbital Adipose Tissue in Active Thyroid Eye Disease Using Next Generation RNA Sequencing Technology. |
| Q60049891 | Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy |
| Q57159636 | Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review |
Search more.